These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
386 related articles for article (PubMed ID: 26734866)
1. Long-term recurrence of nonmelanoma skin cancer after topical methylaminolevulinate photodynamic therapy in a dermato-oncology department. Cabete J; Rafael M; Cravo M; Moura C; Sachse F; Pecegueiro M An Bras Dermatol; 2015; 90(6):846-50. PubMed ID: 26734866 [TBL] [Abstract][Full Text] [Related]
3. Photodynamic therapy with violet light and topical 6-aminolaevulinic acid in the treatment of actinic keratosis, Bowen's disease and basal cell carcinoma. Dijkstra AT; Majoie IM; van Dongen JW; van Weelden H; van Vloten WA J Eur Acad Dermatol Venereol; 2001 Nov; 15(6):550-4. PubMed ID: 11843215 [TBL] [Abstract][Full Text] [Related]
4. [Topical photodynamic therapy in basal and squamous cell carcinoma and penile Bowen's disease with 20% aminolevulinic acid, and exposure to red light and infrared light]. Harth Y; Hirshovitz B Harefuah; 1998 Apr; 134(8):602-5, 672, 671. PubMed ID: 10911421 [TBL] [Abstract][Full Text] [Related]
5. Methyl-aminolevulinate photodynamic therapy for the treatment of actinic keratoses and non-melanoma skin cancers: a retrospective analysis of response in 462 patients. Fai D; Arpaia N; Romano I; Vestita M; Cassano N; Vena GA G Ital Dermatol Venereol; 2009 Jun; 144(3):281-5. PubMed ID: 19528909 [TBL] [Abstract][Full Text] [Related]
6. Investigation of the use of the pulsed dye laser in the treatment of Bowen's disease using 5-aminolaevulinic acid phototherapy. Britton JE; Goulden V; Stables G; Stringer M; Sheehan-Dare R Br J Dermatol; 2005 Oct; 153(4):780-4. PubMed ID: 16181460 [TBL] [Abstract][Full Text] [Related]
13. Comparison of red and green light in the treatment of Bowen's disease by photodynamic therapy. Morton CA; Whitehurst C; Moore JV; MacKie RM Br J Dermatol; 2000 Oct; 143(4):767-72. PubMed ID: 11069454 [TBL] [Abstract][Full Text] [Related]
14. Efficacy of photodynamic therapy with topical 5-aminolevulinic acid using intense pulsed light for Bowen's disease. Hasegawa T; Suga Y; Mizuno Y; Haruna K; Ogawa H; Ikeda S J Dermatol; 2010 Jul; 37(7):623-8. PubMed ID: 20629828 [TBL] [Abstract][Full Text] [Related]
16. Methyl aminolaevulinate-photodynamic therapy for actinic keratoses, squamous cell carcinoma in situ and superficial basal cell carcinoma employing a square wave intense pulsed light device for photoactivation. Downs AM; Bower CB; Oliver DA; Stone CA Br J Dermatol; 2009 Jul; 161(1):189-90. PubMed ID: 19416229 [No Abstract] [Full Text] [Related]
17. Factors predicting pain and effect of oral analgesia in topical photodynamic therapy. Hambly RA; Mansoor N; Quinlan C; Shah Z; Lenane P; Ralph N; Moloney FJ Photodermatol Photoimmunol Photomed; 2017 May; 33(3):176-179. PubMed ID: 28196277 [No Abstract] [Full Text] [Related]
18. Methyl aminolevulinate-PDT for actinic keratoses and superficial nonmelanoma skin cancers. Ortiz-Policarpio B; Lui H Skin Therapy Lett; 2009; 14(6):1-3. PubMed ID: 19609473 [TBL] [Abstract][Full Text] [Related]
19. Periungual Bowen's Disease in a 12-Year-Old Boy Treated with Photodynamic Therapy. Hyun DJ; Seo SR; Kim DH; Yoon MS; Lee HJ Pediatr Dermatol; 2016; 33(2):e82-3. PubMed ID: 26764086 [TBL] [Abstract][Full Text] [Related]
20. Intralesional photodynamic therapy induces apoptosis in basal cell carcinoma and Bowen's disease through caspase 3 and granzyme B. Evangelou G; Koumaki D; Fragiadaki I; Chaniotis V; Farrar MD; Karatzi C; Sotiriou E; Giannikaki E; Katoulis A; Papadakis M; Lallas A; Stefanidou M; Krueger-Krasagakis S; Rhodes LE; Krasagakis K J Eur Acad Dermatol Venereol; 2023 Jul; 37(7):1311-1317. PubMed ID: 36924124 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]